Propofol and children - What we know and what we do not know

Paediatric Anaesthesia

Volumn 21, Issue 3, 2011, Pages 247-254

  Rigby Jones, Ann E ^a   Sneyd, J Robert ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

children; pharmacodynamics; pharmacokinetics; propofol

Indexed keywords

LIVER ENZYME; PROPOFOL;

BILE DUCT ATRESIA; BODY SIZE; BODY WEIGHT; DRUG BLOOD LEVEL; HUMAN; METABOLIC ACIDOSIS; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; REVIEW;

ALGORITHMS; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; BODY WEIGHT; CHILD; CONSCIOUSNESS MONITORS; DRUG DELIVERY SYSTEMS; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; PROPOFOL;

EID: 79951605297     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2010.03454.x     Document Type: Review

References (60)

1. Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-48.
2. Saint-Maurice C, Cockshott ID, Douglas EJ, et al. Pharmacokinetics of propofol in young children after a single dose. Br J Anaesth 1989; 63: 667-670. (Pubitemid 20019092)
3. Raoof AA, van Obbergh LJ, Verbeeck RK,. Propofol pharmacokinetics in children with biliary atresia. Br J Anaesth 1995; 74: 46-49.
4. Jones RD, Chan K, Andrew LJ,. Pharmacokinetics of propofol in children. Br J Anaesth 1990; 65: 661-667. (Pubitemid 20372099)
5. Kataria BK, Ved SA, Nicodemus HF, et al. The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology 1994; 80: 104-122. (Pubitemid 24033610)
6. Murat I, Billard V, Vernois J, et al. Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches. Anesthesiology 1996; 84: 526-532. (Pubitemid 26092524)
7. Reed MD, Yamashita TS, Marx CM, et al. A pharmacokinetically based propofol dosing strategy for sedation of the critically ill, mechanically ventilated pediatric patient. Crit Care Med 1996; 24: 1473-1481. (Pubitemid 26313747)
8. Rigby-Jones AE, Nolan JA, Priston MJ, et al. Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 2002; 97: 1393-1400. (Pubitemid 35417436)
9. Peeters MY, Prins SA, Knibbe CA, et al. Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery. Anesthesiology 2006; 104: 466-474.
10. Allegaert K, Peeters MY, Verbesselt R, et al. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth 2007; 99: 864-870. (Pubitemid 351773375)
11. Allegaert K, de Hoon J, Verbesselt R, et al. Maturational pharmacokinetics of single intravenous bolus of propofol. Pediatr Anesth 2007; 17: 1028-1034. (Pubitemid 47481127)
12. Schuttler J, Ihmsen H,. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 2000; 92: 727-738. (Pubitemid 30130176)
13. Gepts E, Camu F, Cockshott ID, et al. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66: 1256-1263. (Pubitemid 18024603)
14. Anderson BJ, Allegaert K, Holford NH,. Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr 2006; 165: 819-829. (Pubitemid 44627767)
15. Kleiber M,. Body size and metabolism. Hilgardia 1932; 6: 315-333.
16. Anderson BJ, Holford NH,. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 2009; 24: 25-36.
17. Knibbe CA, Zuideveld KP, Aarts LP, et al. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults. Br J Clin Pharmacol 2005; 59: 705-711. (Pubitemid 40835504)
18. Peeters MY, Allegaert K, Blusse van Oud-Alblas HJ, et al. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model. Clin Pharmacokinet 2010; 49: 269-275.
19. Shangguan WN, Lian Q, Aarons L, et al. Pharmacokinetics of a single bolus of propofol in Chinese children of different ages. Anesthesiology 2006; 104: 27-32.
20. Alcorn J, McNamara PJ,. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 2002; 41: 959-998. (Pubitemid 35168438)
21. Anderson BJ,. Pediatric models for adult target-controlled infusion pumps. Pediatr Anesth 2010; 20: 223-232.
22. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-1516. (Pubitemid 29254792)
23. Struys MM, Coppens MJ, De Neve N, et al. Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology 2007; 107: 386-396. (Pubitemid 47329536)
24. Parke TJ, Stevens JE, Rice AS, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-616.
25. Bray RJ,. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8: 491-499. (Pubitemid 28523410)
26. Cremer OL, Moons KG, Bouman EA, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357: 117-118. (Pubitemid 32094917)
27. MCA/CSM. Long term, high dose propofol (Diprivan) infusion. Curr Probl Pharmacovigilence 2001; 27: 6.
28. MCA/CSM. Clarification: propofol (Diprivan) infusion contraindication. Curr Probl Pharmacovigilence 2002; 28: 6.
29. Fudickar A, Bein B,. Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol 2009; 75: 339-344.
30. Wolf A, Weir P, Segar P, et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001; 357: 606-607. (Pubitemid 32179617)
31. Withington DE, Decell MK, Al Ayed T,. A case of propofol toxicity: further evidence for a causal mechanism. Pediatr Anesth 2004; 14: 505-508. (Pubitemid 38758673)
32. Schenkman KA, Yan S,. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med 2000; 28: 172-177. (Pubitemid 30091048)
33. Jenkins IA, Playfor SD, Bevan C, et al. Current United Kingdom sedation practice in pediatric intensive care. Pediatr Anaesth 2007; 17: 675-683. (Pubitemid 46911067)
34. Absalom A, Amutike D, Lal A, et al. Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization. Br J Anaesth 2003; 91: 507-513. (Pubitemid 37258593)
35. Absalom A, Kenny G,. 'Paedfusor' pharmacokinetic data set. Br J Anaesth 2005; 95: 110.
36. Rigouzzo A, Girault L, Louvet N, et al. The relationship between bispectral index and propofol during target-controlled infusion anesthesia: a comparative study between children and young adults. Anesth Analg 2008; 106: 1109-1116. (Pubitemid 351450533)
37. Minto CF, Schnider TW, Gregg KM, et al. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology 2003; 99: 324-333. (Pubitemid 36909558)
38. Munoz HR, Cortinez LI, Ibacache ME, et al. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults. Anesthesiology 2004; 101: 1269-1274. (Pubitemid 39564981)
39. Wakeling HG, Zimmerman JB, Howell S, et al. Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness? Anesthesiology 1999; 90: 92-97.
40. Struys MM, De Smet T, Depoorter B, et al. Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology 2000; 92: 399-406. (Pubitemid 30078337)
41. Mortier E, Struys M,. Effect site modelling and its application in TCI. Acta Anaesthesiol Belg 2000; 51: 149-152.
42. Cortinez LI, Munoz HR, Lopez R,. Pharmacodynamics of propofol in children and adults: comparison based on the auditory evoked potentials index. Rev Esp Anestesiol Reanim 2006; 53: 289-296.
43. Hull D,. Guidelines for the ethical conduct of medical research in children. Arch Dis Child 2000; 82: 177-182.
44. Marx CM, Smith PG, Lowrie LH, et al. Optimal sedation of mechanically ventilated pediatric critical care patients. Crit Care Med 1994; 22: 163-170.
45. Murray DM, Thorne GC, Rigby-Jones AE, et al. Electroencephalograph variables, drug concentrations and sedation scores in children emerging from propofol infusion anaesthesia. Pediatr Anesth 2004; 14: 143-151. (Pubitemid 38304894)
46. Jeleazcov C, Ihmsen H, Schmidt J, et al. Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children. Br J Anaesth 2008; 100: 509-516. (Pubitemid 351773602)
47. Munoz HR, Cortinez LI, Ibacache ME, et al. Effect site concentrations of propofol producing hypnosis in children and adults: comparison using the bispectral index. Acta Anaesthesiol Scand 2006; 50: 882-887. (Pubitemid 44034241)
48. Rigouzzo A, Servin F, Constant I,. Pharmacokinetic-pharmacodynamic modeling of propofol in children. Anesthesiology 2010; 113: 343-352.
49. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-1182. (Pubitemid 28216859)
50. Watcha MF,. Investigations of the bispectral index monitor in pediatric anesthesia: first things first. Anesth Analg 2001; 92: 805-807. (Pubitemid 32239113)
51. Sadhasivam S, Ganesh A, Robison A, et al. Validation of the bispectral index monitor for measuring the depth of sedation in children. Anesth Analg 2006; 102: 383-388. (Pubitemid 43152582)
52. Overly FL, Wright RO, Connor FA Jr, et al. Bispectral analysis during pediatric procedural sedation. Pediatr Emerg Care 2005; 21: 6-11. (Pubitemid 40130228)
53. Davidson AJ,. Monitoring the anaesthetic depth in children-an update. Curr Opin Anaesthesiol 2007; 20: 236-243. (Pubitemid 46701339)
54. Wallenborn J, Kluba K, Olthoff D,. Comparative evaluation of Bispectral Index and Narcotrend Index in children below 5 years of age. Pediatr Anesth 2007; 17: 140-147. (Pubitemid 46089379)
55. Klockars JG, Hiller A, Ranta S, et al. Spectral entropy as a measure of hypnosis in children. Anesthesiology 2006; 104: 708-717.
56. Tobias JD, Grindstaff R,. Bispectral index monitoring during the administration of neuromuscular blocking agents in the pediatric intensive care unit patient. J Intensive Care Med 2005; 20: 233-237. (Pubitemid 43093894)
57. Tirel O, Wodey E, Harris R, et al. Variation of bispectral index under TIVA with propofol in a paediatric population. Br J Anaesth 2008; 100: 82-87. (Pubitemid 351773424)
58. Park HJ, Kim YL, Kim CS, et al. Changes of bispectral index during recovery from general anesthesia with 2% propofol and remifentanil in children. Pediatr Anesth 2007; 17: 353-357. (Pubitemid 46365106)
59. WorldSIVA. Open TCI Initiative. Accessed 8 November, 2010.
60. Absalom AR, Mani V, De Smet T, et al. Pharmacokinetic models for propofol - defining and illuminating the devil in the detail. Br J Anaesth 2009; 103: 26-37.